Searchable abstracts of presentations at key conferences in endocrinology

ea0086oc6.6 | Thyroid | SFEBES2022

Can systemic cytokines predict relapse of graves’ disease?

Lane Laura , Jash Simran , Cheetham Tim , Razvi Salman , Pearce Simon

Background and Aims: Relapse in GravesÂ’ disease (GD) often occurs after antithyroid drugs (ATD) are withdrawn, however there is a lack of robust predictive biomarkers for relapse and little mechanistic insight into its pathophysiology. B-cell related cytokines and chemokines may reflect humoral immune activity and therefore be predictive of outcome. The purpose of this study was to evaluate serum B-cell activating factor (BAFF), Chemokine ligand 13 (CXCL13), A-proliferati...